Your Ride. Your Impact.

Since 2015, Ride for Cancer powered by BMO Bank of Montreal has raised over $572,000 to improve cancer treatment, research and patient care at the QEII Health Sciences Centre. To date, fundraising efforts has purchased an additional apheresis machine – a crucial piece of equipment in blood cancer treatment – and endobronchial ultrasound (EBUS) technology, which provides a safer and less-invasive alternative to diagnosing lung cancer and lymphoma. Beyond funding vital equipment, Ride for Cancer has funded support programs to help patients through their cancer journey, as well as local research to discover improved treatments for aggressive cancers.

Our Ride for Cancer community is working together to improve cancer care for Atlantic Canadians. But we’re not stopping there…we’re not even close. On September 30, we’re going BIGGER.

With a goal of raising $500,000 net, this year we are making an impact on: 

1. ADVANCED SYSTEMIC THERAPY EQUIPMENT– to double capacity and shorten wait times

As the largest cancer centre east of Montréal, the QEII provides the full spectrum of cancer care to patients from across Atlantic Canada. From radiation treatment, to surgery and systemic therapy, the QEII’s Cancer Centre is the academic hub that directs cancer care standards across Nova Scotia.

Systemic therapy is a form of cancer treatment that enters the bloodstream and travels throughout the body to fight cancer cells. Every day, hundreds of specialized doses, like chemotherapy, are prepped and tailored for the treatment of individual patients. These patients need multiple treatments over a lengthy period of time, requiring many hours spent at the QEII’s Cancer Centre. Approximately 50% of all cancer patients will need systemic therapy.

Cancer therapy preparation equipment will be purchased with funds raised through this year's Ride for Cancer. By updating this equipment, we will create an immediate impact by doubling the preparation capacity and increasing our ability to participate in more clinical trials. This also opens up the potential to introduce state-of-the-art technology, such as bar-coding, within the preparation suite.


2. LOCAL RESEARCH - unlocking new treatments for leukemia patients

Proceeds will also fund local blood cancer researchers, like Dr. Jason Berman at Dalhousie University. Acute myeloid leukemia (AML) is an aggressive blood cancer requiring better treatments. Dr. Jason Berman will use zebra fish to determine why children with a newly discovered gene abnormality have a particularly deadly form of AML and study how these genes impact blood development causing leukemia.


3. PATIENT AND FAMILY SUPPORT - resources and education materials on the cancer journey

For every $1,000 raised by a Ride for Cancer participant, it provides 20 cancer patients in Atlantic Canada with Empower Packs custom care packages designed to empower patients and their families with the knowledge and tools they need to take control of their disease.

BMO Logo